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B cell progenitors require paracrine signals such as interleukin-7 (IL-7) provided by bone marrow stromal cells for 
proliferation and survival. Yet, how B cells regulate access to these signals in vivo remains unclear. Here we show that proB 
and IL-7+ cells form a cell circuit wired by IL-7R signaling, which controls CXCR4 and focal adhesion kinase (FAK) expression 
and restricts proB cell movement due to increased adhesion to IL-7+CXCL12Hi cells. PreBCR signaling breaks this circuit by 
switching the preB cell behavior into a fast-moving and lower-adhesion state via increased CXCR4 and reduced FAK/α4β1 
expression. This behavioral change reduces preB cell exposure to IL-7, thereby attenuating IL-7R signaling in vivo. Remarkably, 
IL-7 production is downregulated by signals provided by preB cells with unrepaired double-stranded DNA breaks and by 
preB acute lymphoblastic leukemic cells. Combined, these studies revealed that distinct cell circuits control the quality 
and homeostasis of B cell progenitors.
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Introduction
B cell development is highly dependent on IL-7 receptor signaling 
mediated by IL-7 (Grabstein et al., 1993; Peschon et al., 1994; von 
Freeden-Jeffry et al., 1995; Puel et al., 1998; Carvalho et al., 2001). 
At the proB cell stage, IL-7R signals mostly through the JAK1/3 
and STAT5a/b pathway to promote survival and proliferation. 
However, at the preB cell stage, IL-7R signaling plays both pos-
itive and negative roles in B cell development. It is still required 
for preB cell proliferation and anti-apoptotic gene expression 
(e.g., Bcl2, Bcl2l1, and Mcl1). Yet, it also inhibits Igκ germline 
transcription through STAT5 binding of Eκi and recruitment of 
Polycomb repressive complex 2, which results in histone H3 ly-
sine 27 trimethylation and inaccessibility of Jκ and Cκ regions 
to the RAG proteins (Mandal et al., 2011). Furthermore, IL-7R–
induced cyclin D3 expression negatively regulates Vκ transcrip-
tion, resulting in inhibited RAG protein accessibility to the Vκ 
genes (Powers et al., 2012). IL-7R signaling in preB cells has also 
been proposed to repress Rag1 and Rag2 transcription (Johnson 
et al., 2008) through phosphatidylinositol-3-OH kinase (PI3K) 
activation, AKT phosphorylation, and Foxo1 inactivation (Ochiai 
et al., 2012). Thus, IL-7R signaling simultaneously promotes preB 
cell survival and proliferation while also profoundly inhibiting 
IgL chain gene rearrangement and developmental progression 
into the immature B cell stage. How can preB cells then balance 
positive and negative effects of IL-7R signaling to allow develop-
mental progression in vivo?
Some evidence suggests that preB cell receptor (preBCR) signal-
ing activates IRF4 expression (Thompson et al., 2007). In addition 
to enabling IgL gene rearrangement, IRF4 promotes CXCR4 expres-
sion and increases preB cell migration toward CXCL12 (Johnson 
et al., 2008). BCR signaling at the immature B cell stage also pro-
motes CXCR4 upregulation and increases B-lineage cell migration 
to CXCL12 in vitro and in vivo (Beck et al., 2014). Initial attempts to 
identify bone marrow (BM) stromal cell subsets that express IL-7 
and CXCL12, using an anti–IL-7 antibody and Cxcl12GFP/+ reporter 
mice, concluded that nonhematopoietic CXCL12-GFPHi stromal cells 
did not express IL-7. Reciprocally, cells detected with an anti–IL-7 
antibody were not marked by Cxcl12-driven GFP expression. It was 
therefore concluded that two distinct stromal cell subsets existed 
in the BM of adult mice that expressed either IL-7 or CXCL12, but 
not both (Tokoyoda et al., 2004). In light of these findings, Singh 
and colleagues proposed that preBCR-mediated upregulation of 
CXCR4 localizes preB cells near CXCL12-producing cells and, in this 
manner, lowers IL-7R signaling by positioning preB cells in IL-7low 
microenvironments (Johnson et al., 2008). This model gained trac-
tion because it provided a reasonable explanation for how preB cells 
coordinate positive and negative roles of IL-7R signaling in vivo 
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(Clark et al., 2014). However, blinded analyses of IL-7–producing 
cells in tissue sections of wild-type and IL-7–deficient mice stained 
with an anti–IL-7 antibody failed to reliably identify IL-7+ cells, 
and, since then, multiple IL-7 reporter mice have been generated 
(Mazzucchelli et al., 2009). Using Il7GFP/+ knock-in mice and Il7-CFP 
transgenic mice in combination with Cxcl12dsRed/+ reporter mice, we 
identified a nonhematopoietic Lepr+ cell subset with mesenchymal 
progenitor potential that not only expressed IL-7 but also expressed 
the highest amount of CXCL12 of all BM cells (Cordeiro Gomes et 
al., 2016). Furthermore, hematopoietic multipotent progenitor cells 
and common lymphoid progenitor cells are strictly dependent on 
CXCR4 for optimal IL-7R signaling and consequently for lymphoid 
lineage development. However, these findings raise the possibility 
that preBCR signaling would actually promote preB cell localization 
near CXCL12Hi cells where IL-7–production is highest. Thus, how 
preB cells regulate this juxtaposition between preBCR and IL-7R 
signaling to successfully progress into the immature and mature B 
cell stages still remains enigmatic (Lim et al., 2017).
The behavior of proB and preB cells in vivo is presumably 
physiologically relevant also in extreme situations such as when 
B cell precursors cannot repair double-stranded DNA breaks 
(DSBs). Indeed, unrepaired RAG-mediated DSBs result in the ac-
tivation of NF-κB and SpiC-controlled gene expression programs 
that downregulate preBCR signaling components and upregulate 
the expression of genes involved in lymphocyte migration and 
adhesion (Bredemeyer et al., 2008; Bednarski et al., 2016). Fur-
thermore, Ikaros-deficient proB cells and both mouse and human 
Ikaros-deficient BCR-ABL–expressing preB acute lymphoblastic 
leukemic (preB-ALL) cells are aberrantly adherent to stromal 
cells (Joshi et al., 2014; Schwickert et al., 2014; Schjerven et al., 
2017). Thus, understanding how normal and DSB-damaged proB 
and preB cells behave in vivo and interact with BM niches can 
lead to novel insights into B cell development and homeostasis.
Here we show that proB cells are essentially nonmotile and 
intimately associated with CXCL12+ IL-7+ mesenchymal cells. 
CXCL12 guides proB cells toward IL-7Hi niches that in turn acti-
vate IL-7R signaling to promote CXCR4 and focal adhesion kinase 
(FAK; encoded by Ptk2) expression. This enforces proB cell/IL-7+ 
cell interactions and favors IL-7–mediated proB cell expansion. 
PreBCR signaling then breaks this circuit by further increasing 
CXCR4 expression while substantially lowering α4β1/FAK-medi-
ated adhesion to VCAM-1. Consequently, preB cells spend little 
time in direct contact with CXCL12- and IL-7–producing cells, 
attenuating IL-7R signaling in vivo. Remarkably, IL-7+ niche cells 
modulate IL-7 production in response to the quality of neighbor-
ing preB cells: preB cells with unrepaired DSBs and BCR-ABL+ 
preB-ALLs instruct IL-7+ niche cells to decrease IL-7 and CXCL12 
production, which significantly reduces endogenous B lympho-
poiesis. These findings provide evidence supporting a model in 
which cell circuits operate in the BM to control the number and 
quality of B cell precursors.
Results
Overlapping BM niches for proB and preB cells
Although proB and preB cells can be readily distinguished by flow 
cytometry using a variety of cell surface markers (Fig. 1 A), these 
phenotypic differences were insufficient for their reliable visual-
ization in situ (not shown). To overcome this limitation, we took 
advantage of the fact that proB cells express significantly higher 
amounts of Rag1 and Rag2 than preB cells and used RAG2: GFP 
knock-in mice (Monroe et al., 1999) to examine the distribution 
of proB and preB cells in vivo. As expected, cKit+ CD19+ CD93Hi 
IgM− proB cells expressed bimodal and notoriously high amounts 
of RAG2: GFP, whereas cKit− CD19+ CD93Hi IgM− preB cells ex-
pressed detectable but significantly lower amounts of RAG2: GFP 
(Fig. 1 B). A short, 20-min pulse in vivo with the thymidine ana-
logue BrdU confirmed that RAG2: GFP is predominantly abundant 
in BrdU-negative proB and preB cells (Fig. 1 B), in agreement with 
studies showing active RAG2 phosphorylation, ubiquitination, 
and degradation during the S phase of the cell cycle (Desiderio, 
2010). To examine the distribution of proB and preB cells in re-
lation to CXCL12 and IL-7+ mesenchymal progenitor cells (MPCs), 
we reconstituted lethally irradiated Il7GFP/+ Cxcl12dsred/+ mice with 
BM cells isolated from RAG2: GFP knock-in mice. Analyses of 
femur whole mounts by confocal microscopy revealed that RAG2: 
GFPHi B-lineage cells were slightly closer to CXCL12+ IL-7+ MPCs 
than RAG2: GFPLo B cells, whereas the distribution of RAG2: GFPLo 
B cells was similar to that of randomly picked CD19− cells marked 
by DAPI+ nuclei (Fig. 1, C and D). Furthermore, ∼50% of RAG2: 
GFPHi proB cells (29 out of 62) were found in direct contact with a 
CXCL12+ IL-7+ cell that also directly interacted with a RAG2: GFPLo 
preB cell, although only ∼15% of RAG2: GFPLo preB cells (40 out of 
284) in contact with a CXCL12+ IL-7+ cell had a neighboring RAG2: 
GFPHi proB cell (Fig. 1 E).
Next, we analyzed mice in which B cell development is blocked 
at the proB (Rag1−/−) and at the preB (Rag1−/− IghB1-8/+) cell stage. 
As before, we generated BM chimeras by transplanting BM cells 
from either mice into lethally irradiated Il7GFP/+ Cxcl12dsred/+ mice 
and analyzed proB and preB cell distribution in femur whole 
mounts by confocal microscopy. ProB cells were found in direct 
contact with IL-7+ CXCL12+ stromal cells at slightly but signifi-
cantly higher frequencies than preB cells (Fig. 1, F and G). In sum-
mary, while the large majority of proB and preB cells occupy IL-7 
niches, a small fraction of preB cells is more frequently found in 
niches farther away from IL-7+ cells.
ProB and preB cell dynamic behavior in vivo
Next, we sought to understand the mechanisms by which preB 
cells position away from IL-7–expressing cells, with the broader 
goal of understanding whether positional differences in B cell 
precursors are physiologically important. To gain insight into 
how proB and preB cells localize in the BM, we visualized their 
behavior in vivo by intravital two-photon microscopy, as pre-
viously described (Pereira et al., 2009). We generated mice 
in which proB cells are labeled genetically with Rag1GFP/GFP (B 
cell development is arrested at the proB cell stage) and mice 
in which preB cells are similarly labeled but development is 
allowed to proceed until the preB cell stage due to transgenic 
expression of a recombined heavy chain locus (Igh3-83/+). While 
proB cells were predominantly static and in direct contact with 
CXCL12+ cells, with a few proB cells migrating short distances, 
nearly all preB cells were motile (Fig. 2 A and Video 1). PreB 
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displacement (Fig. 2 C) when compared with proB cells. This 
drastic difference in dynamic behavior was also reflected in 
the prolonged time individual proB cells spent in contact with 
CXCL12+ cells throughout a 30-min imaging period (Fig. 2 D), 
as well as in an increased average time individual proB cells 
spent in contact with individual CXCL12+ cells when compared 
with preB cells (Fig. 2 E). These observations showed that the 
small differences found in proB and preB cell static positioning 
in situ (Fig. 1) were caused by dramatically different dynamic 
behaviors in vivo, and suggest that they might be physiologi-
cally relevant.
As developing B cell migration in vivo is controlled by CXCR4 
(Beck et al., 2014), we measured CXCR4 expression in proB and 
preB cells and migration in vitro using a transwell assay. Indeed, 
CXCR4 expression is enhanced in preB cells (Fig. 3 A), and preB 
cells migrated toward a gradient of CXCL12 significantly more 
than did proB cells (Fig. 3 B). Nevertheless, this relatively small 
difference in migration toward CXCL12 in vitro contrasted with a 
Figure 1. Localization of proB and preB cells in relationship to IL-7– and CXCL12-producing cells. (A) Gating strategy for proB and preB cells. Left, BM 
cells gated on live CD19+ cells. Right, cKit expression distinguishes proB from preB cells. (B) Left, RAG2: GFP fusion protein expression in proB (red) and preB 
(blue) cells isolated from RAG2: GFP mice. Filled histograms show background fluorescence in wild-type preB cells. RAG2: GFP expression in proB (middle 
panel) and preB (right panel) in S phase (BrdU+) and in non–S phase (BrdU–). (C) Longitudinal 30-µm-thick femur section from lethally irradiated Il7GFP/+ 
Cxcl12dsRed/+ mouse reconstituted with RAG2: GFP BM cells stained to detect GFP (green), CD19 (cyan), and nuclei (DAPI, not shown). Cxcl12-dsRed fluorescent 
protein (red) was directly visualized. Data were pooled from two independent experiments (n = 2). (D) Quantification of proB (RAG2: GFPHi) and preB (RAG2: 
GFPLo) cells in contact with IL-7– and CXCL12-producing cells (see Materials and methods for details). Bars indicate average; circles indicate individual mice. 
(E) Quantification of colocalized RAG2: GFPHi (proB) and RAG2: GFPLo (preB) in contact with individual IL-7+ CXCL12+ cells (bottom right). Example of a RAG2: 
GFPHi (arrowheads) and a RAG2: GFPLo (arrows) cell in contact with the same IL-7+ cell. The same datasets were analyzed as in D. Error bars indicate SD. (F) 
Longitudinal 30-µm-thick section of a femur from a lethally irradiated Il7GFP/+ Cxcl12dsRed/+ mouse reconstituted with Rag1−/− (top panels) or Rag1−/− IghB1-8/+ 
(bottom panels) BM cells, stained to detect GFP (green) and CD19 (cyan). Cxcl12-dsRed was directly visualized (red). An entire femur/mouse was acquired; 
data were pooled from three independent experiments (n = 3). (G) Frequency of proB (Rag1−/−) and preB (Rag1−/− IghB1-8/+) cells in contact with IL-7+ CXCL12+ 
cells. Bars indicate average; circles depict individual mice. *, P < 0.05 by unpaired Student’s t test. Scale bars, 50 µm. Data in all panels are representative of 
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remarkably different dynamic behavior in vivo, suggesting that ad-
ditional mechanisms might be involved in vivo. Other than CXCR4, 
B-lineage cells required α4β1 integrin-mediated adhesion to 
VCAM-1 for retention and migration within the BM (Pereira et al., 
2009; Beck et al., 2014), and proB cells expressed higher amounts 
of α4β1 than preB cells (Fig. 3 C). Previous studies showed that the 
transcription factor Ikaros acts as a transcriptional repressor of 
multiple genes involved in cell migration and adhesion (Schjerven 
et al., 2013; Joshi et al., 2014; Schwickert et al., 2014), of which FAK 
(encoded by Ptk2) played a major role in supporting aberrant proB 
cell adhesion to stromal cells and VCAM-1 in vitro (Schwickert et 
al., 2014). FAK is also required for the retention of Ikaros-suffi-
cient proB cells in the BM (Park et al., 2013). Interestingly, proB 
cells expressed significantly higher amounts of FAK (and Ikaros) 
than preB cells (Fig. 3, D and E), suggesting that proB cells might be 
more adherent to VCAM-1 than preB cells. To test this hypothesis, 
we coated transwells with a range of VCAM-1 concentrations and 
quantified proB and preB cell migration toward a CXCL12 gradi-
ent in vitro. As expected, VCAM-1–mediated adhesion prevented 
proB cell migration significantly more than in preB cells (Fig. 3 F). 
Combined, these data strongly suggest that the reduced migratory 
behavior of proB cells is due to a small reduction in CXCR4 expres-
sion in combination with increased FAK/α4β1 integrin-mediated 
adhesion to VCAM-1.
ProB cell/IL-7+ cell circuits control IL-7R signaling
The observation that proB cells are predominantly nonmotile 
and stably adherent to BM IL-7– and CXCL12-producing MPCs 
suggests that IL-7R signaling is constitutively high in proB cells, 
Figure 2. ProB and preB cell migratory behavior in vivo. (A) Distribution of GFP+ proB cells (green, top left) and of preB cells (green, bottom left) in BM 
calvaria of lethally irradiated Cxcl12dsRed/+ mice reconstituted with Rag1GFP/GFP (top panels) or with Rag1GFP/GFP Igh3-83/+ (bottom panels) BM cells. Movement 
of GFP+ B cells tracked for 30 min in vivo by IVM. Colored lines (right panels) represent cell trajectories. Scale bar, 50 µm. (B) Median velocity (micrometers 
per minute). Each circle represents a single cell analyzed. (C) Mean motility coefficient of proB and preB cells. Cell displacement from starting coordinates is 
plotted against time (minutes). Lines represent the mean motility coefficient from three separate videos per mouse. (D) Time (minutes) spent in direct contact 
with CXCL12+ cells over 30 min. (E) Average time (minutes) proB and preB cells spent in contact with individual CXCL12+ cells. Data are from Video 1. Circles 
represent single cells analyzed. ****, P < 0.00005 by unpaired Student’s t test. Data in all panels are representative of three independent experiments.
Figure 3. CXCR4-mediated migration and VLA4/FAK-mediated adhe-
sion to VCAM-1 in proB and preB cells. (A) CXCR4 expression in proB and 
preB cells. (B) In vitro transwell (5-µm pore) migration assay of C57BL/6 BM 
cells toward CXCL12 gradients. Y axis indicates frequency of migrated cells; x 
axis shows CXCL12 concentration (nanograms per milliliter). (C) α4 integrin 
expression in proB and preB cells. (D) FAK expression (encoded by Ptk2) in 
proB and preB cells. (E) Ikaros (encoded by Ikzf1) expression in proB and preB 
cells. (F) ProB and preB cell migration across VCAM-1–coated transwells (5 
µm) toward CXCL12 gradient (300 ng/ml). Y axis indicates percent reduction 
in migratory cells; x axis shows VCAM-1 concentration (micrograms per mil-
liliter) used for coating transwells. (B and F) Error bars indicate SD of three 
individual experiments. Numbers inside all histograms indicate geometric 
mean fluorescence intensity ± SD (n = 3 mice in each group). *, P < 0.05 by 
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which led us to hypothesize that IL-7R signaling might, in turn, 
regulate the expression of genes involved in proB cell localization 
and dynamic behavior. To test this hypothesis, we conditionally 
deleted IL-7Ra in proB cells by crossing Il7rafl/fl mice with Mb1cre/+ 
mice. B cell development was severely impaired at the proB and 
preB cell stages, which led to an overall reduction in total B cell 
numbers (Fig. 4 A). We confirmed by flow cytometry that IL-7R 
protein expression was not detected on the few proB and preB 
cells that could be found in the BM of Il7rafl/fl Mb1cre/+ mice (data 
not shown). Interestingly, we noted that the proportion of IL-
7Ra–deficient proB and preB cells in the spleen was higher than 
that seen in the spleen of littermate control mice (Fig. 4 B), sug-
gesting that IL-7Ra–deficient B-lineage precursors might be less 
retained in the BM than wild-type counterparts. The few IL-7Ra–
deficient B-lineage cells that nevertheless developed expressed 
significantly reduced amounts of CXCR4 in proB and preB cells 
(Fig. 4 C and data not shown, respectively). Furthermore, IL-7Ra–
deficient proB and preB cells migrated toward CXCL12 in vitro 
with lower efficiency than IL-7Ra–sufficient proB and preB cells, 
while IL-7Ra deficiency had no impact on migration to CXCL12 (or 
CXCR4 expression) in immature B cells that no longer expressed 
IL-7Ra (Fig. 4 D and data not shown, respectively). To further val-
idate these findings, we measured the impact of IL-7Ra signal-
ing on motility and adhesion mechanisms of wild-type proB and 
preB cells developing in vivo. Indeed, IL-7Ra signaling actively 
controlled the proB adhesion program as measured by signifi-
cantly reduced FAK expression after treatment with an anti–IL-
7Ra blocking antibody (clone A7R34) for 36 h (Fig. 4 E), whereas 
α4β1 expression was unchanged (Fig. 4 F). Similar changes were 
observed in IL-7Ra–deficient proB cells (data not shown). To 
test if IL-7Ra signaling also controls proB cell behavior in vivo, 
we analyzed proB cell motility in Rag1GFP/GFP mice treated with 
IL-7Ra blocking antibodies for 36 h by intravital two-photon mi-
croscopy. Although the majority of proB cells remained largely 
sessile, we could detect a subtle but significant increase in the 
mean displacement and median cell velocity of proB cells treated 
with anti–IL-7R antibody (Fig. 4, G and H; and Video 2) that did 
not seem to be caused by active, amoeboid cell motility, given that 
proB cells became more rounded (Fig. 4 I) and presumably less 
adherent to the extracellular matrix. In agreement with this pos-
sibility, proB cells became slightly less associated with CXCL12+ 
cell processes (Fig. 4 J). Loosely adherent proB cells likely become 
more motile as a consequence of shear stress generated by in-
trasinusoidal turbulent blood flow and plasma transudation 
into BM parenchyma (Beck et al., 2014). We propose that CXCR4 
and integrin signaling (α4β1/FAK/VCAM-1) locks proB cells in 
contact with IL-7–producing cells in BM. This tight interaction 
likely drives constitutive IL-7Ra signaling that further promotes 
CXCR4 and FAK/α4β1 integrin-mediated adhesion to IL-7–pro-
ducing cells (Fig. 4 K) in a feed-forward loop manner that resem-
bles a two-cell circuit system (Zhou et al., 2018).
PreBCR signaling breaks the proB/IL-7+ cell circuit to attenuate 
IL-7R signaling at the preB cell stage
In addition to signaling from the preBCR, the transition from 
a constitutively high to an intermittent and low IL-7Ra sig-
naling from proB to preB cells has been proposed to control 
RAG gene expression and Ig light chain gene accessibility 
(Johnson et al., 2008; Ochiai et al., 2012; Clark et al., 2014). We 
reasoned that the rapid movement and reduced time spent in 
contact with CXCL12 and IL-7+ MPCs might enable preB cells 
to attenuate IL-7R signaling in vivo. Furthermore, as preBCR 
signaling induces IRF4 expression and IRF4 drives CXCR4 up-
regulation (Muljo and Schlissel, 2003; Thompson et al., 2007; 
Johnson et al., 2008), we hypothesized that preBCR signaling 
is also responsible for the switch from higher to lower FAK/
α4β1 integrin-mediated adhesion to VCAM-1. Indeed, preB cells 
treated with a cocktail of SYK and BTK inhibitors (fostama-
tinib and ibrutinib, respectively) or the PI3K inhibitor wort-
mannin promoted α4β1 and FAK expression (Fig. 5, A and B), 
whereas stimulatory anti-CD79b antibody treatment reduced 
α4β1 and FAK expression (Fig. 5, C and D), increased CXCR4 ex-
pression in preB cells (data not shown), and increased preB cell 
migration toward CXCL12 (Fig. 5 E). The changes induced by 
anti-CD79b stimulation, albeit also small, were significant and 
sufficient for causing significant differences in α4β1-mediated 
preB cell adhesion to VCAM-1 in vitro (Fig.  5  F). These find-
ings suggested that preB cells acquire rapid motility through 
the combined small but significant and physiologically rele-
vant changes in CXCR4, α4β1, and FAK expression in vivo. To 
test this possibility, we took advantage of the fact that Phil-
adelphia chromosome–positive BCR-ABL preB-ALL cells are 
developmentally arrested at the preB cell stage (Schjerven et 
al., 2017) to measure the effects of increased FAK signaling in 
preB cell behavior in vivo. Indeed, preB-ALL cells retrovirally 
transduced with a Ptk2 expression vector significantly reduced 
their migratory behavior in vivo at day 7 after transplantation 
(Fig. 5, G–I; and Video 3) and increased their time in contact 
with CXCL12Hi stromal cells (Fig. 5, J and K). Combined, these 
findings suggest that productive V(D)J rearrangements in proB 
cells and signaling through the newly assembled preBCR acts 
as a proB/IL-7+ cell circuit breaker through increased CXCR4 
expression and decreased integrin-mediated adhesion, which 
promotes rapid movement between IL-7Hi and IL-7Lo BM mi-
croenvironments (Fig. 5 L). These results are consistent with 
studies showing differential adhesion of B cell precursors to 
VCAM-1 in vitro (Glodek et al., 2003).
Such tight control of preB cell dynamic behavior in vivo lends 
support to the long proposed but never tested hypothesis that 
CXCR4-regulated positioning attenuates IL-7Ra signaling re-
quired for Rag gene reexpression and developmental progres-
sion into the immature B cell stage (Johnson et al., 2008; Clark 
et al., 2014). To experimentally test this model, we antagonized 
the FAK downregulation that normally occurs at the preB cell 
stage by overexpressing Ptk2 (reported by GFP expression) in 
hematopoietic stem cell (HSC)–enriched BM cells from C57BL/6 
mice and analyzed B cell developmental subsets in FAKHi ver-
sus control transduced cells. Lethally irradiated recipient mice 
were reconstituted with empty vector (EV)– or Ptk2-transduced 
HSCs for a period of 4–6 wk. Hematopoietic progenitor cells over-
expressing FAK showed a strong inability to differentiate into 
blood cell types in vivo for unknown reasons, but a few FAKHi 
lymphoid and myeloid cells could nevertheless be detected in the 
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in Ptk2-transduced preB cells, which made it equivalent to that 
detected in EV-transduced proB cells (Fig. 6 A). Furthermore, 
FAKHi preB cells showed significantly higher amounts of phos-
phorylated STAT5a than EV-transduced preB cells (Fig.  6  B), 
suggesting that FAKHi preB cells may have been more exposed 
to IL-7 in vivo. Interestingly, the frequency of FAKHi cells within 
the preB cell and subsequent B cell subsets was fourfold lower 
than FAKHi cells within the proB stage (Fig. 6 C). We cannot rule 
out the possibility that increased FAK signaling prevents preB 
cell proliferation. However, these findings suggest that antago-
nism of the normal FAK downregulation that occurs at the preB 
cell stage blocks the transition between the proB and preB cell 
stages, which significantly reduces mature B cell production in 
vivo. To validate these findings and to gain further insight, we 
asked if proximity to IL-7 alters the preB cell cycle and perturbs 
RAG2 protein stability in vivo. To address this question, we over-
expressed the R334X desensitization mutant form of CXCR4 that 
causes WHIM (warts, hypogammaglobulinemia, infections, and 
myelokathexis) syndrome (Gorlin et al., 2000; Hernandez et al., 
2003; Balabanian et al., 2005) in HSCs isolated from RAG2: GFP 
mice and reconstituted lethally irradiated recipient mice with 
EV- or CXCR4R334X-transduced HSCs for a period of 4–6 wk. 
CXCR4R334X-transduced preB cells expressed higher amounts of 
CXCR4 than EV-transduced preB cells (Fig. 6 D). Interestingly, 
overexpression of the CXCR4R334X mutant increased the fraction 
of preB cells that was in the S phase of the cell cycle, as measured 
Figure 4. Relationship between IL-7R signaling and CXCR4-mediated proB cell motility. (A) Total number of developing B cell subsets from femur and 
tibia (left) and from spleen (right) of mice conditionally deficient in IL-7Ra in B-lineage cells: Mb1Cre/+ Il7raFl/+ (black) and Mb1Cre/+ Il7raFl/Fl (gray) mice. (B) Mobi-
lization index: ratio of proB and preB cell number in the spleen to that in the BM of Mb1Cre/+ Il7raFl/+ (Het, black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) mice. Circles 
depict individual mice. (C) CXCR4 geometric mean fluorescence intensity (GMFI) in proB cells (left) and preB cells (right) gated as in A in Mb1Cre/+ Il7raFl/+ (Het, 
black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) mice. (D) In vitro transwell (5 µm) migration assay of Mb1Cre/+ Il7raFl/+ (Het, black) and Mb1Cre/+ Il7raFl/Fl (KO, gray) BM 
cells toward CXCL12 gradients. Y axis indicates frequency of migrated cells; x axis shows CXCL12 concentration (nanograms per milliliter). (A–D) Lines indicate 
mean; circles depict individual mice (n = 3). (E) FAK expression in proB cells isolated from C57BL/6 mice untreated (littermate controls, black) or treated with 
anti–IL-7Ra blocking antibodies (gray) for 36 h. (F) α4 integrin expression in proB cells isolated from C57BL/6 mice treated with isotype control (black) or anti–
IL-7Ra blocking antibody (gray) for 36 h. (E and F) Numbers inside histograms indicate geometric mean fluorescence intensity ± SD (n = 3 mice in each group). 
(G) Mean motility coefficient of proB cells in mice untreated (black) or treated with IL-7Ra blocking antibodies (gray) for 36 h. GFP+ proB cells were visualized 
in calvaria of lethally irradiated Cxcl12dsRed/+ mice reconstituted with BM cells from Rag1GFP/GFP mice. ProB cell movement was tracked for 30 min in vivo by 
IVM. Lines represent the mean motility coefficient from three separate videos per mouse. (H) Median velocity. Circles, individual cells. (I) Measurement of cell 
axis ratio of GFP+ proB cells before (black) and after (gray) treatment with anti–IL-7Ra blocking antibody. Each point represents an individual cell analyzed. (J) 
Frequency of GFP+ proB cells found in contact with Cxcl12-dsRed cells in mice treated with IL-7Ra blocking antibody (gray) or untreated (black). Circles, average 
from individual fields of view. (K) Model of the proB/IL-7+ cell circuit. *, P < 0.05; **, P < 0.005; ***, P < 0.0005; ****, P < 0.00005 by unpaired Student’s t test. 
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by a 20-min pulse of BrdU incorporation in vivo (Fig. 6 E). As 
expected, it also reduced the fraction of RAG2: GFPHi preB cells 
(Fig.  6, F and G). These findings suggest that enforcement of 
preB cell interactions with IL-7+ cells is sufficient for reducing 
the time preB cells spend in the G1 phase of the cell cycle and 
hence to perturb RAG2 protein stability. These changes were 
reflected in a significant expansion of CXCR4R334X-Hi proB cells 
when compared with granulocytes (Fig. 6 H), a result that is con-
sistent with increased IL-7R signaling due to increased exposure 
to IL-7 (Carvalho et al., 2001; Rother et al., 2016). In contrast, 
CXCR4R334X-Hi preB cells were reduced by threefold, presumably 
due to reduced RAG2 protein half-life and time spent in the G1 
phase of the cell cycle. This led to a greater than threefold reduc-
tion in the generation of CXCR4R334X-Hi mature B cells (Fig. 6 H). 
Reduced granulocyte production from CXCR4R334X-Hi progenitors 
is likely a consequence of reduced differentiation capacity of 
HSCs that express CXCR4 desensitization mutant (McDermott 
et al., 2015; Freitas et al., 2017).
Preleukemic preB and BCR-ABL preB cells regulate IL-7 
production in vivo
Previous studies suggested that RAG-mediated DSBs elicit an 
NF-κB–driven and Spic-driven gene expression program in preB 
cells that downregulates the expression of preBCR signaling 
components and upregulates the expression of genes involved 
in cell migration (Bredemeyer et al., 2008; Bednarski et al., 
2016). Thus, we reasoned that the accumulation of unrepaired 
DSBs that occurs in Artemis (encoded by Dclre1c)-deficient preB 
cells might alter their distribution in relationship to IL-7+ cells 
in vivo. To address this question, we compared the distribution 
of Igh and Bcl2 transgenic Rag1−/− preB cells (no RAG-mediated 
DSBs) and of Igh and Bcl2 transgenic Dclre1c−/− preB cells (ac-
cumulated unrepaired DSBs) relative to IL-7+ and CXCL12+ cells. 
However, we did not detect significant differences in Artemis-de-
ficient and -sufficient preB cells in vivo (Fig. 7, A and B), which 
was consistent with no measurable differences in CXCR4 expres-
sion (Fig. 7 C). Unexpectedly, we noted that Il7 expression was 
Figure 5. Relationship between preBCR signaling and CXCR4- and integrin-mediated preB cell motility. (A) FAK geometric mean fluorescence intensity 
(GMFI) in preB cells from C57BL/6 mice treated with BCR signaling inhibitors (blue, fostamatinib and ibrutinib) or vehicle (red), or with PI3K inhibitor wortmannin 
(green) or vehicle (red) for 6 h in vitro. (B) α4 integrin expression in preB cells of C57BL/6 mice treated as in A. Numbers indicate geometric mean fluorescence 
intensity ± SD (n = 3 mice per condition). (C and D) FAK geometric mean fluorescence intensity (C) and α4 integrin expression (D) in preB cells treated with 
stimulatory CD79b antibody for 6 h in vitro. Con., control. (A and C) Bars indicate mean; circles depict individual mice/assays. (D) Numbers inside histogram 
indicate geometric mean fluorescence intensity ± SD (n = 3 individual mice/assays). (E) Transwell migration toward CXCL12 of preB cells treated with stimula-
tory CD79b antibody for 6 h in vitro. Y axis indicates frequency of migrated cells; x axis indicates CXCL12 concentration (nanograms per milliliter). (F) PreB cell 
migration across VCAM-1–coated transwells (5 µm) toward CXCL12 gradient (300 ng/ml). Y axis indicates percent reduction in migrated cells; x axis indicates 
VCAM-1 concentration (micrograms per milliliter) used for coating transwells. (E and F) Circles represent average of three independent experiments. Error 
bars indicate SD. (G) Distribution of EV-transduced GFP+ preB-ALL cells (green, top left) and of FAK-transduced GFP+ preB-ALL cells (green, bottom left) in 
BM calvaria of Cxcl12dsRed/+ mice at day 14 after transplantation. Movement of GFP+ B cells tracked for 30 min by IVM. Colored lines represent cell trajectories 
(right panels). Scale bar, 50 µm. (H) PreB-ALL cell velocity (micrometers per minute). Each circle represents a single cell analyzed. (I) Mean motility coefficient 
of EV- and FAK-transduced preB-ALL cells. Cell displacement from starting coordinates is plotted against time (minutes). Lines depict the mean motility 
coefficient from three videos imaged/mouse. (J) Time (minutes) spent in direct contact with CXCL12+ cells over a 30-min period. (K) Average time (minutes) 
that EV- and FAK-transduced preB-ALL cells spent in direct contact with individual CXCL12+ cells. (J and K) Circles represent single cells. Data in panels G–K 
are from Video 3. (L) Model of the preB/IL-7+ cell circuit. **, P < 0.005; ***, P< 0.0005; ****, P < 0.00005 by unpaired Student’s t test. Data in all panels are 
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lower in MPCs isolated from the BM of mice in which preB cells 
were deficient in Artemis (Fig. 7, D and E), suggesting that IL-7+ 
cells sense the quality of neighboring preB cells through signals 
provided by Artemis-deficient preB cells. As Artemis deficiency 
is a risk factor for leukemogenesis, we finally asked if bona fide 
preB-ALLs also regulate IL-7 production in BM. We adoptively 
transferred 105 BCR-ABL preB-ALL cells into nonirradiated 
Cxcl12dsRed/+ Il7GFP/+ mice and measured Il7-GFP and Cxcl12-dsRed 
expression in MPCs 2 wk after transfer. Remarkably, Il7-GFP and 
Cxcl12-dsRed expression was significantly reduced in mice re-
cipient of BCR-ABL preB-ALLs (Fig. 7, F–I). Furthermore, termi-
nal deoxynucleotidyl transferase expression was significantly 
reduced in nonleukemic proB cells (Fig. 7, J and K), consistent 
with reduced IL-7R signaling in these cells (Wei et al., 2000; 
Carvalho et al., 2001; Rother et al., 2016). These changes resulted 
in a threefold reduction in endogenous nonleukemic B cell pro-
duction (Fig. 7 L), while granulocytes were only reduced by ∼20% 
(Fig. 7 M). Combined, these results suggest that preB/IL-7+ cell 
circuits evolved to not only regulate preB cell transition into the 
immature B cell compartment, but also to facilitate the removal 
of dangerous preleukemic preB cells (Fig. 7 N).
Discussion
B lymphocyte progenitors have been proposed to occupy distinct 
microenvironments in the BM according to their developmental 
stage (Dorshkind, 1990; Jacobsen and Osmond, 1990; Pereira et 
al., 2009; Mourcin et al., 2011). ProB cells are highly dependent 
on extrinsic growth factors (mostly IL-7, stem cell factor, and pos-
sibly FLT3 ligand) for survival and proliferation (Grabstein et al., 
1993; Peschon et al., 1994; von Freeden-Jeffry et al., 1995; Waskow 
et al., 2002; Sitnicka et al., 2003). Most, if not all, of these factors 
are produced by Leptin receptor (Lepr)–positive nonhematopoi-
etic cells that express the highest amounts of CXCL12 in the BM 
Figure 6. Relationship between enforced positioning within IL-7+ niches, RAG2 protein stability, and preB cell developmental progression. (A) Over-
expression of FAK (Ptk2) or EV reported by GFP in retrovirally transduced BM cells isolated from C57BL/6 mice. FAK expression in preB cells transduced with 
EV (left) or FAK (middle). Representative histogram of preB cells transduced with FAK compared with proB cells transduced with EV (right). (B) pSTAT5a in 
EV- or FAK-transduced preB cells. (C) Frequency of EV- (left) or FAK-transduced (right) GFPHi BM B-lineage cells and granulocytes from femur and tibia. (D) 
Overexpression of CXCR4 R334X (WHIM mutation) in retrovirally transduced BM cells isolated from RAG2: GFP knock-in mice. Transduced cell subsets reported 
by human CD4. CXCR4 expression in EV- (left) or CXCR4R334X-transduced (right) preB cells gated on hCD4Lo and hCD4Hi cells. (E) BrdU incorporation in EV- (left) 
or CXCR4R334X-transduced preB cells. Numbers indicate the frequency of BrdU+ cells. (F) RAG2: GFP expression in gated hCD4Hi and hCD4Lo preB cells (EV, left; 
CXCR4R334X, right). (G) Quantification of RAG2: GFP fusion protein geometric mean fluorescence intensity (GMFI). Circles depict individual mice. (H) Frequency 
of hCD4Hi B-lineage cells and granulocytes in femur and tibia BM. Circles indicate mean ± SD (n = 3). (C and H) Error bars indicate SD of three independent 
experiments. Numbers inside histograms (A, B, and D) indicate geometric mean fluorescence intensity ± SD (n = 3 mice in each group). Data in all panels were 
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(Ding et al., 2012; Cordeiro Gomes et al., 2016). In later stages, 
preB cell survival and proliferation continue to depend on IL-7, 
albeit to a lower extent than proB cells due to pro-survival and 
pro-proliferative signals mediated by the preBCR (Clark et al., 
2014). However, IL-7R signaling also prevents preB cell devel-
opmental progression by inhibiting Rag gene expression and Ig 
light chain gene accessibility (Ochiai et al., 2012). Therefore, it 
was unclear how preB cells achieve an appropriate level of IL-7R 
signaling that allows cells to developmentally progress in vivo. 
Here we show that proB and preB cells display remarkably dif-
ferent dynamic behaviors in vivo. ProB cells are predominantly 
nonmotile and intimately associated with IL-7+ cells. IL-7R sig-
naling controls this stable cell–cell interaction by promoting high 
CXCR4 and FAK expression. This type of feed-forward regulation 
resembles an unstable two-cell circuit (Zhou et al., 2018) in that 
it would predict uncontrolled proB cell growth under normal 
homeostatic conditions. Instead, our data suggest that cell cir-
cuit stability is partly ensured by preBCR signaling, which acts 
as a circuit breaker by altering the behavior of preB cells in vivo. 
Importantly, this is achieved through a relatively subtle increase 
in CXCR4 expression and reduction in α4β1/FAK expression. 
These combined changes in chemoattractant receptor expres-
sion and integrin signaling presumably promote a switch from 
a nonmotile and highly adherent to a highly motile and less ad-
herent state. This change in behavior reduces the time preB cells 
spend in contact with IL-7+ cells in the BM, thereby attenuating 
IL-7R signaling. Indeed, IL-7R signaling could be significantly 
increased in preB cells by simply overexpressing FAK or a desen-
sitization mutant CXCR4 (R334X), which reduced RAG2 protein 
half-life and inhibited both preB cell and subsequent B cell de-
velopmental stages by more than threefold. Given that proB cells 
do not undergo uncontrolled cell growth in Rag-deficient mice, 
other negative feedback mechanisms independent of preBCR sig-
naling likely operate to ensure cell circuit stability.
A surprising observation from our studies was the finding 
that IL-7 production is downregulated by signals provided by 
preB cells bearing unrepaired DSBs. It is possible that normal 
preB cells undergoing transient DSB responses also down-
regulate IL-7 production and that Artemis deficiency allows 
DSBs to persist long enough for changes in IL-7 expression to 
be detected. Nevertheless, these observations revealed an un-
suspected layer of regulation of preB/IL-7+ cell circuits that 
may have evolved to prevent the survival and proliferation of 
preleukemic preB cells. However, the fact that BCR-ABL+ preB-
ALLs could also induce IL-7 (and CXCL12) downregulation sug-
gests that leukemic cells exploit certain cell circuit pathways 
to reduce the production of nonleukemic B-lineage cells. This 
would suggest that normal and leukemic preB cells compete 
for similar factors, with nutrients fueling anabolic metabolism 
being likely candidates. Future studies addressing nutrient 
requirements of normal and leukemic progenitor B cells will 
be of high value.
Figure 7. DNA repair deficiency in preB cells and control of IL-7 expression in vivo. (A) Longitudinal 30-µm-thick femur section of lethally irradiated 
Il7GFP/+ Cxcl12dsRed/+ mice reconstituted with Rag1−/− VH147Igh Eμ-Bcl2 (top panels) or Dclrec1−/− VH147Igh Eμ-Bcl2 BM stained to detect GFP (green), CD19 
(cyan), and cell nuclei (DAPI, not shown). Cxcl12-dsRed fluorescent protein (red) was directly visualized. Scale bar, 50 µm. Images are representative of three 
individual mice. (B) Quantification of Artemis-deficient (blue) and -sufficient (red) preB cells in contact with IL-7– and CXCL12-producing cells. Bars indicate 
mean; circles depict individual mice (n = 3). (C) CXCR4 expression in Artemis-deficient (blue) and -sufficient (red) preB cells in vivo. Numbers indicate geometric 
mean fluorescence intensity (GMFI) ± SD (n = 3). (D) Il7-GFP expression in nonhematopoietic Lepr+ BM cells of lethally irradiated Il7GFP/+ mice reconstituted 
with Rag1−/− VH147Igh Eμ-Bcl2 or Dclrec1−/− VH147Igh Eμ-Bcl2 BM cells. (E) Quantification of Il7-GFP expression from D. (F) Geometric mean fluorescence 
intensity of Il7-GFP expression in nonhematopoietic Lepr+ BM cells of Il7GFP/+ mice 2 wk after transfer of 105 BCR-ABL transduced preB cells. (G) Quantification 
of Il7-GFP expression from F. (H) Geometric mean fluorescence intensity of Cxcl12-dsRed expression in nonhematopoietic Lepr+ BM cells of Cxcl12dsred/+ Il7GFP/+ 
mice 2 wk after transfer of 105 BCR-ABL preB cells. (I) Quantification of Cxcl12-dsRed expression from H. Lines indicate mean; circles depict individual mice 
analyzed (n = 3). (J) Terminal deoxynucleotidyl transferase (Tdt) expression in nonleukemic proB cells isolated from mice described in H. (K) Quantification of 
terminal deoxynucleotidyl transferase expression from J. (L and M) Total CD19+ host B lymphocytes (L) and granulocytes (M) 2 wk after transfer of 105 BCR-ABL 
transduced preB cells. (E, G, and K–M) Lines indicate mean; circles depict individual mice analyzed (n = 3). (N) Model of damaged preB or preB-ALL cell/IL-7+ 
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The fact that DSB-damaged preB cells and normal preB cells 
express similar amounts of CXCR4 and are similarly distrib-
uted in the BM suggests that DSB-damaged and normal B cell 
progenitors interact with the same niche. It remains unclear 
if the presence of a single DSB-damaged preB cell is sufficient 
for downregulating IL-7 expression in individual IL-7+ cells that 
harbor nondamaged B cell progenitors, or if a threshold of dam-
aged preB cells is needed. Nevertheless, these observations raise 
the interesting possibility that individual IL-7+ cells are regu-
lated independently, and also that individual cells may return 
back to expressing normal amounts of IL-7. In this case, indi-
vidual IL-7+ cells would be expected to act as single niche units 
of lymphopoiesis.
In conclusion, our findings provide support for a novel con-
ceptual model of B cell development where cell circuits between 
proB, preB, and IL-7+ cells are wired to control the number and 
developmental progression of B cell progenitors, while being 
equipped with negative feedback loops that may disfavor the 
survival of preleukemic cells. Our findings also suggest that 
BCR-ABL+ preB-ALLs exploit IL-7 downregulation to favor leu-
kemic cell growth at the expense of nonleukemic B cells. It will 
be important to unravel the molecular and cellular mechanism(s) 
controlling IL-7 production in BM niches.
Materials and methods
Mice
C57BL/6 (CD45.2), Boy/J (CD45.1), and Il7raF/F mice were ob-
tained from the Jackson Laboratory. Il7raF/F mice were crossed 
to Mb1cre/+ mice (Pelanda et al., 2002). Rag1GFP/+ mice (Kuwata et 
al., 1999) were crossed to each other to generate Rag1GFP/GFP mice. 
Rag1−/−, IghB1-8/+, and Rag2: GFP mice were kindly provided by Dr. 
David Schatz (Yale University, New Haven, CT). Dclrec1−/−:uIgH: 
BCL2 and Rag1−/−:uIgH: BCL2 mice were kindly provided by Dr. 
Jeffrey Bednarski (Washington University in St. Louis, St. Louis, 
MO). Cxcl12DsRed/+ and Il7GFP/+ mice were from our internal col-
ony. A detailed list of all mouse strains and other materials and 
reagents used is provided (Table 1). Mice were maintained under 
specific pathogen–free conditions and used according to proto-
cols approved by the Yale University Institutional Animal Care 
and Use Committee.
BM chimeras
Il7GFP/+Cxcl12DsRed/+ mice were lethally irradiated with two doses 
of 550 rads separated by 3 h and reconstituted with 3 × 106 whole 
BM cells of either Rag1−/−, Rag1−/− IghB1-8/+, Rag1GFP/GFP, Rag1GFP/GFP 
Igh3-83/+, Dclrec1−/−:VH147Igh: BCL2, or Rag1−/−:VH147Igh: BCL2. 
Chimeric mice were analyzed 4 wk after reconstitution. Boy/J 
mice were lethally irradiated in the same way and reconstituted 
with CXCR4R334X or EV-transduced RAG2: GFP BM.
Tissue preparation, cell enumeration, and flow cytometry
BM cells were flushed from both femurs and tibias in DMEM 
containing 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomy-
cin, 1 mM L-glutamine, and 10 mM Hepes. Spleens were mashed 
through 70-µm strainers containing 5 ml of the same media. Cells 
were counted with a Beckman Coulter Counter.
Flow cytometry analyses and cell gating were performed as 
previously described (Nevius et al., 2015; Cordeiro Gomes et al., 
2016). Briefly, proB cells were gated as CD19+IgM−CD93+cKit+, 
preB cells as CD19+IgM−IgD−CD93+cKit−, immature IgD− as 
CD19+IgM+IgD−CD93+, immature IgDlo as CD19+IgM+IgDloCD93+, 
and Mat.B as CD19+IgM+IgDhiCD93−. Dead cell dyes (DAPI) were 
used for all freshly stained (nonpermeabilized) samples.
Two-photon intravital imaging
Mice were anesthetized with a mixture of ketamine and xyla-
zine before immobilization on a custom-made stereotactic appa-
ratus. Laser-scanning microscopy images were collected using 
an Olympus BX61 fluorescence microscope with a 20× 0.95 NA 
water-immersion objective and dedicated single-beam TriM 
Scope II (LaVision BioTec). The image acquisition software used 
was Imspector. Stacks of 18–21 optical sections of 3-µm z-spac-
ing were acquired every 30 s for 30 min. The laser was tuned to 
a wavelength of 880 nm. Videos with excessive levels of tissue 
drifting were excluded from analysis.
Retroviral transductions of hematopoietic stem and 
progenitor cells and BCR-ABL preB-ALLs
The R334X CXCR4 cytoplasmic tail mutant plasmid generation 
has been described (Beck et al., 2014). pMXs-puro-EGFP-FAK 
was acquired from Addgene (plasmid #38194). Donor Rag2: GFP 
or C57BL/6 mice were injected intraperitoneally with 300 µl of 
10-mg/ml 5-fluorouracil (5-FU). 5 d after 5-FU injection, BM was 
harvested and spin infected with harvested retrovirus for 2 h at 
2,450 rpm at room temperature. Recipient mice were then recon-
stituted with the transduced BM for 4 wk before analysis.
BCR-ABL+ preB-ALL adoptive transfer
BCR-ABL cells were prepared as previously described (Schjerven 
et al., 2017). For imaging experiments, 105 BCR-ABL cells trans-
duced with a retroviral vector containing GFP alone or Ptk2-
IRES-GFP were adoptively transferred into Cxcl12dsRed/+ mice via 
intravenous tail vein injection. 14 d later, BM calvaria were imaged 
by two-photon intravital microscopy (IVM). For Il7-GFP evalua-
tion experiments (Fig. 7), 105 BCR-ABL cells transduced with a 
retroviral vector containing GFP were adoptively transferred 
into Il7GFP/+ mice via intravenous tail vein injection and compared 
with mock injection. 14 d later, mice were euthanized and BM 
IL-7+ mesenchymal cells were analyzed by flow cytometry.
In vivo IL-7R antibody blockade
Mice were intravenously injected with PBS or 200 µg antibody 
(clone A7R34). In all cases, treatments lasted for 36  h before 
mice were analyzed.
Transwell migration and adhesion assay
Chemotaxis assays were performed with 106 BM cells or 2.5 × 
105 BCR-ABL cells. Cells were incubated for 30 min in RPMI con-
taining 0.5% fatty acid–free BSA, 1% penicillin/streptomycin, 1% 
L-glutamine, and 1% Hepes. Cells were then deposited onto the 
top of a transwell containing 5-µm pores and allowed to migrate 
for 3 h toward varying concentrations of CXCL12 in the bottom 
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Table 1. List of reagents, DNA constructs and mouse strains, sources, and catalog numbers
Reagent or resource Source Identifier
Antibodies
APC BrdU Flow Kit BD Biosciences Cat#557892
Donkey polyclonal anti-goat biotin Jackson ImmunoResearch Cat#705-065-003
Donkey polyclonal anti-rabbit Alexa488 Life Technologies Cat#A21206
Donkey polyclonal anti-rat Alexa488 Jackson ImmunoResearch Cat#112-545-003
Donkey polyclonal anti-rat biotin Jackson ImmunoResearch Cat#112-065-003
FITC BrdU Flow Kit BD Biosciences Cat#559619
Goat polyclonal anti-GFP Rockland Cat#600-101-215
Mouse monoclonal anti-human CD4 biotin BD Biosciences Clone RPA-T4; Cat#555345
Mouse monoclonal anti-human CD4 PE BD Biosciences Clone L200; Cat#550630
Mouse monoclonal anti-mouse FAK Invitrogen Clone ZF002; Cat#39-6500
Rat monoclonal anti-CXCR4 biotin eBioscience Clone 2B11; Cat#13-9991-82
Rat monoclonal anti-mouse CD19 BV711 BioLegend Clone 6D5; Cat#115555
Rat monoclonal anti-mouse CD19 PE BioLegend Clone 6D5; Cat#115508
Rat monoclonal anti-mouse CD93 APC BioLegend Clone AA4.1; Cat#136510
Rat monoclonal anti-mouse cKIT BV421 BioLegend Clone ACK2; Cat#135124
Rat monoclonal anti-mouse cKIT BV711 BioLegend Clone 2B8; Cat#105835
Rat monoclonal anti-mouse IgD BV711 BioLegend Clone 11-26c.2A; Cat#405731
Rat monoclonal anti-mouse IgD PE BioLegend Clone 11-26c.2A; Cat#405706
Rat monoclonal anti-mouse IgG1 PE BD Biosciences Clone A85-1; Cat#550083
Rat monoclonal anti-mouse IgM PECy7 eBioscience Clone II/41; Cat#25-5790-81
Rat monoclonal anti-mouse Ikaros PE BioLegend Clone 2A9; Cat#653304
Rat monoclonal anti-mouse Integrin α4 PE Southern Biotech Clone PS/2; Cat#1520-09L
Rat monoclonal anti-mouse pSTAT5 (Y694) BV421 BD Biosciences Clone 47/Stat5; Cat#562077
Streptavidin Alexa700 Life Technologies Cat#S21383
Streptavidin BV605 BioLegend Cat#405229
Streptavidin BV711 BioLegend Cat#405241
Bacterial and virus strains
“Subcloning efficiency” DH5α competent cells (F− Φ80lacZΔM15 
Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk−, mk+) phoA supE44 




Chemicals, peptides, and recombinant proteins
DMSO American Bioanalytical CAS: 67 -68 -5
Ibrutinib (PCI-32765) Selleck Chemicals Cat#S2680





Experimental models: Cell lines
HEK293T Gift from Dr. David Schatz, Yale 
University
BCR-ABL Schjerven et al., 2017 Gift from Dr. Hilde Schjerven, University 
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pended in 40 µl of staining buffer before analysis for 40 s by flow 
cytometry. For adhesion assays, transwells were precoated with 1, 
3, or 10 µg/ml mouse VCAM-1 at 4°C overnight before performing 
the assay as otherwise described.
In vitro stimulations and inhibitions
Approximately 106 whole BM cells were cultured in IMDM con-
taining 20% FBS, 1% penicillin/streptomycin, 1% L-glutamine, 
1% Hepes, and 50 µM β-mercaptoethanol. For all stimulations, 
anti-CD79b (clone HM79b) was given to cells at a concentration 
of 10 µg/ml for 8 h. Stimulations were confirmed by observing 
IgM internalization of mature B lymphocytes by flow cytometry. 
For inhibitions, cells were given a combination of fostamatinib 
(1 µM) and ibrutinib (1 µM) or wortmannin (1 µM) for 6 h and 
were compared with vehicle (DMSO) control.
BM immunofluorescence microscopy
The distinction of proB and preB cells based on the intensity of 
RAG2: GFP expression was determined as follows: a histogram 
distribution of voxels for RAG2: GFP in individual CD19+ cells was 
generated from individual images captured from longitudinal 
femur sections (z = 30 µm). The top 10% of CD19+ cells with the 
highest GFP expression (voxels) was classified as proB (GFPHi), 
and the remaining cells were classified as preB (GFPLo). In Fig. 1, 
D, E, and G, and Fig. 7 B, each circle represents the average fre-
quency of proB or preB cells in contact with CXCL12+ cells ob-
tained in one mouse. The average frequency was calculated from 
>200–300 proB and preB cells analyzed from 10 images obtained 
from longitudinal femur sections imaged by confocal microscopy.
Femurs and tibias were fixed in 4% paraformaldehyde in 
PBS for 5 h followed by washing with PBS three times. Bones 
were submerged in 30% sucrose overnight before being snap 
frozen in optimal cutting temperature media (Tissue-Tek) in 
a bath of hexane surrounded by dry ice. Bone was shaved off 
using a cryostat (Leica) until the surface of BM was visible. The 
bone was then placed in a bath of room temperature PBS to melt 
remaining optimum cutting temperature compound, followed 
by permeabilization in 0.1% Triton X-100 for 2 h. Bones were 
stained with primary antibodies for 3 d at 4°C, followed by sec-
ondary antibodies for 1 d at 4°C and tertiary antibodies for 1 d at 
4°C. Images were acquired on a Leica SP8 confocal microscope 
using a 20× oil-immersion objective (0.75 NA). For random posi-
Reagent or resource Source Identifier
Experimental models: Organisms/strains
Mus musculus, strain Mb1cre Pelanda et al., 2002 Gift from J.G. Cyster, University of 
California, San Francisco
Mus musculus, strain Il7rtm1.1Asin/J (Il7rFlox) McCaughtry et al., 2012 The Jackson Laboratory, Cat#022143
Mus musculus, strain RAG2: GFP Monroe et al., 1999 Gift from Dr. David Schatz, Yale 
University
Mus musculus, strain Rag1−/− Mombaerts et al., 1992 Gift from Dr. David Schatz, Yale 
University
Mus musculus, strain Rag1GFP Kuwata et al., 1999 Our internal colony
Mus musculus, strain IghB1-8 (B6.129P2(C)-Ightm2Cgn/J) Sonoda et al., 1997 Gift from Dr. David Schatz, Yale 
University
Mus musculus, strain Igh3-83 (C.129P2(B6)-Igktm1Rsky Ightm2Rsky/PldJ) Pelanda et al., 1997 The Jackson Laboratory, Cat#011074
Mus musculus, strain Il7GFP Miller et al., 2013 Gift from Dr. Susan Kaech, Yale 
University
Mus musculus, strain Cxcl12DsRed Ding and Morrison, 2013 Gift from Dr. Sean Morrison, University 
of Texas Southwestern Medical Center




pMXs-puro-EGFP-FAK Hara et al., 2008 Addgene plasmid #38194
pMSCV CXCR4R334X IRES GFP Pereira laboratory N/A
pMSCV CXCR4R334X IRES hCD4 This paper N/A
Software and algorithms
FlowJo version 9.6.4 Tree Star http:// www .flowjo .com
Imaris version 7.2 Bitplane http:// www .bitplane .com/ imaris/ imaris
Other
N/A
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tioning analysis, spots placed on DAPI+ and CD19− cells in Imaris 
software were given a random identifier in Microsoft Excel 
using the RAN DBE TWE EN() function, and randomly assigned 
spots were analyzed.
BrdU incorporation in vivo
Rag2: GFP mice were injected with 1 mg BrdU for 20 min before 
immediate euthanasia. BM cells were harvested, cell surface 
markers were stained, and then cells were fixed, and BrdU was 
detected using BD PharMingen BrdU Flow Kits per the manufac-
turer’s specification.
Statistics
Student’s two-tailed t test or χ2 tests were performed using 
PRI SM 6 (Graphpad Software) or Excel (Microsoft). P values 
<0.05 were considered significant.
Online supplemental material
Video 1 shows proB and preB cell movement within calvaria BM 
of live mice. Video 2 shows proB cell movement in calvaria BM of 
live mice treated with PBS or with 200 µg of anti–IL-7Ra antibody 
(clone A7R34). Video 3 shows the in vivo behavior of BCR-ABL+ 
preB cells retrovirally transduced to overexpress FAK or EV.
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